Comprehensive Study Notes on Linear Accelerator (LINAC) Systems and Radiation Therapy Principles

Historical Context and Development of the Linear Accelerator

The linear accelerator, commonly referred to as a LINAC, is the primary device utilized in modern radiotherapy for delivering external beam treatments to cancer patients. These machines are capable of treating various parts and organs of the body by delivering high-energy X-ray beams or electrons directly to the tumor region. The historical evolution of these devices began with the work of Wilderoe in $1928$, who developed models to accelerate heavy ions. It was not until the late $1940s$ that electron accelerators were specifically developed through the efforts of Fry, Ginzton, and Chodorow. Modern LINACs operate through complex interactions where the magnetic field of electrons interacts with electromagnetic microwaves, propelling them through an accelerator section. This process is often compared to a surf rider being propelled forward by water waves. The energy of the resulting beam is directly proportional to the length of the accelerator structure; thus, a longer structure produces higher electron speeds and higher energy for both X-ray and electron beams.

Functional Components and Internal Mechanics

The internal assembly of a LINAC begins with the power supply, which provides $DC$ power to the modulator. The modulator then supplies $DC$ pulses of a few microseconds in duration to both the electron gun and the microwave source (either a magnetron or a klystron). The electron gun consists of a concave tungsten cathode backed by a tungsten heating coil, which produces the electrons to be injected into the accelerator structure. The accelerator structure itself is an evacuated cylindrical chamber, described as being $1 \text{ to } 2 \text{ cm}$ long and divided into cavities. Each cavity has a diameter of approximately $10 \text{ cm}$, a length of $2.5 \text{ cm to } 5 \text{ cm}$, and is polished to a mirror-like finish. For the microwave power, a magnetron functions as a high-power oscillator, generating pulses of several microseconds at a repetition rate of several hundred pulses per second. In contrast, a klystron is not a generator but a microwave amplifier that must be driven by a low-powered microwave oscillator. These microwaves are conducted from the klystron or magnetron into the accelerator structure via a wave guide, which is a copper tube filled with insulating gas.

The Treatment Head and Beam Modification

The treatment head of a LINAC is designed to provide sufficient shielding against leakage radiation in accordance with protection guidelines, typically consisting of a thick shell made of high-density materials like lead, tungsten, or a lead-tungsten alloy. Key components within the head include the bending magnet, which turns the electron beam vertically downward at angles of $90^{\circ}$ or $270^{\circ}$ (often using a $270^{\circ}$ achromatic bending magnet) before it strikes the target or scattering foil. In Photon (X-ray) Mode, the electron beam strikes an X-ray target to produce a forward-peaked beam, which is then shaped by a flattening filter to ensure a homogenous intensity across the entire field. In Electron Mode, the target is retracted, and the scattering foil is placed in the path of the $3 \text{ mm}$ pencil beam to widen it for clinical use. An ion chamber, which is a hollow tube filled with gas (usually air), monitors the beam and can switch off the equipment once an adequate radiation dose is reached. The head also contains a field-defining light and a radio-lucent foil mirror to simulate the radiation beam area visually, along with cross-wires to define the beam's center.

Collimation, Field Shaping, and Accessories

Radiation beams are restricted to the desired size using collimators. The primary collimator is a fixed component, while the secondary collimator is movable to define specific field sizes. In electron mode, an electron applicator (or cone) is required because the restriction offered by primary and secondary collimators is insufficient for the desired field sizes. To further modify the beam, wedges or wedge filters—wedge-shaped absorbers—are used to create a progressive decrease in intensity across the beam, tilting the isodose curves. Additional shaping is achieved using lead blocks or Cerrobend blocks. Cerrobend is a specialized alloy composed of $1/2 \text{ bismuth, } 4 \text{ lead, and } 1/4 \text{ cadmium and tin}$. For clinical shielding, these blocks are typically $1 \text{ cm}$ thick for electron beams and $7 \text{ cm}$ thick for photon beams. The gantry serves as the main body of the machine where these major components are mounted, including the patient couch, imager, and the range finder, which scales distances from target to surface in centimeters.

Classification of External Beam Radiotherapy (EBRT) Machines

Radiotherapy machines are classified based on their operating potentials and clinical applications. Grenz Ray Therapy uses very soft X-rays at potentials below $20 \text{ kV}$; due to low penetration, it is primarily historically used for skin lesions. Contact Therapy (Endocavitary) operates at $40 \text{ to } 50 \text{ kV}$ with a tube current of $2 \text{ mA}$ and a very short Source-to-Skin Distance (SSD) of $2 \text{ cm}$. Superficial Therapy Units produce X-rays from $50 \text{ to } 150 \text{ kV}$ for treating tumors at a depth of about $5 \text{ mm}$, typically using an SSD of $15 \text{ to } 20 \text{ cm}$ and a tube current of $5 \text{ to } 8 \text{ mA}$. Orthovoltage Therapy (Deep Therapy) operates between $150 \text{ and } 500 \text{ kV}$ and requires filters to reduce soft X-rays for reasonable penetration. Supervoltage Therapy refers to the range of $500 \text{ to } 1,000 \text{ kV}$. Finally, Megavoltage Therapy involves beams of energy $1 \text{ MV}$ or greater, including gamma rays from radionuclides. Specialized megavoltage units include the Van de Graaf generator ($2 \text{ MV}$), the Betatron (which accelerates electrons in a circular "doughnut" orbit using changing magnetic fields), and the Microtron (a hybrid between a cyclotron and a LINAC structure).

Radiobiological Principles and the 4 R's of Radiotherapy

The clinical effectiveness of radiation is governed by the 4 R's of Radiotherapy. First, Repair of DNA assumes that tumor cells are less capable of repairing genetic damage than normal cells. Second, Reoxygenation involves the proliferation of tumor cells being limited by nutrient and oxygen availability; as therapy progresses, previously hypoxic cells may become reoxygenated and more sensitive. Third, Redistribution accounts for the fact that cells are more sensitive to radiation during specific phases of their cycles. Fourth, Repopulation refers to radiation's ability to stimulate cell division; in tumors, this is not controlled by homeostatic mechanisms, necessitating additional doses to counteract the regrowth. Fractionation is the administration of treatment in a planned series of daily doses (typically $5 \text{ days a week}$) to allow normal cell recovery while depleting tumor cells. Alternatively, the protraction technique delivers the dose continuously at a lower rate, though this is generally less effective due to the lower dose rate and longer irradiation time.

Tolerance Doses of Tissues and Target Volumes

The total radiation dose tolerated by normal tissue varies based on the volume irradiated and the fractionation schedule. Specific tolerance doses for various tissues include: Thyroid ($30 \text{-} 40 \text{ Gy}$), Liver ($35 \text{-} 40 \text{ Gy}$), Heart, Lymphoid, Bone Marrow, and Spinal Cord ($40 \text{-} 50 \text{ Gy}$), Gastrointestinal tract ($50 \text{-} 60 \text{ Gy}$), Brain ($60 \text{-} 70 \text{ Gy}$), Peripheral Nerve and Mucosa ($65 \text{-} 77 \text{ Gy}$), and Bone, Cartilage, and Muscle (> 70 \text{ Gy}). In treatment planning, various volumes are defined: the Gross Tumor Volume (GTV) is the palpable or visible extent of the malignant growth; the Clinical Target Volume (CTV) includes the GTV and subclinical microscopic disease; the Planning Target Volume (PTV) encompasses the CTV plus margins for movement and treatment patterns; the Treatment Volume is enclosed by a specified isodose surface selected by the oncologist; and the Irradiated Volume is the tissue receiving a dose significant to its tolerance. Clinicians must also monitor for Hot Spots (areas of high radiation accumulation due to beam overlap or skinfolds) and Cold Spots (areas of low accumulation due to missed radiation).